Apricus Bioscience (APRI +12%) pops after saying its subsidiary NexMed USA receives clearance...

|About: Apricus Biosciences, Inc (APRI)|By:, SA News Editor

Apricus Bioscience (APRI +12%) pops after saying its subsidiary NexMed USA receives clearance from the FDA for its third OTC drug, Diphenhydramine-D, for the treatment of itching associated with insect bites, small cuts and other minor skin irritations.